198 related articles for article (PubMed ID: 16471266)
1. [The Bcl-2 family of proteins as drug targets].
Mazars A; Geneste O; Hickman J
J Soc Biol; 2005; 199(3):253-65. PubMed ID: 16471266
[TBL] [Abstract][Full Text] [Related]
2. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities.
Chan SL; Yu VC
Clin Exp Pharmacol Physiol; 2004 Mar; 31(3):119-28. PubMed ID: 15008953
[TBL] [Abstract][Full Text] [Related]
3. Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists.
Wang S; Yang D; Lippman ME
Semin Oncol; 2003 Oct; 30(5 Suppl 16):133-42. PubMed ID: 14613034
[TBL] [Abstract][Full Text] [Related]
4. A view to a kill: ligands for Bcl-2 family proteins.
Rutledge SE; Chin JW; Schepartz A
Curr Opin Chem Biol; 2002 Aug; 6(4):479-85. PubMed ID: 12133724
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 family proteins as therapeutic targets.
Czabotar PE; Lessene G
Curr Pharm Des; 2010; 16(28):3132-48. PubMed ID: 20687882
[TBL] [Abstract][Full Text] [Related]
6. The chemical biology of apoptosis: Revisited after 17 years.
Yang S; Mao Y; Zhang H; Xu Y; An J; Huang Z
Eur J Med Chem; 2019 Sep; 177():63-75. PubMed ID: 31129454
[TBL] [Abstract][Full Text] [Related]
7. Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.
Merino D; Lok SW; Visvader JE; Lindeman GJ
Oncogene; 2016 Apr; 35(15):1877-87. PubMed ID: 26257067
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 family members as molecular targets in cancer therapy.
Marzo I; Naval J
Biochem Pharmacol; 2008 Oct; 76(8):939-46. PubMed ID: 18638457
[TBL] [Abstract][Full Text] [Related]
9. Novel genetic and peptide-based strategies targeting the Bcl-2 family, an update.
Aouacheria A
Recent Pat DNA Gene Seq; 2009; 3(2):123-9. PubMed ID: 19519582
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
Richardson A; Kaye SB
Curr Mol Pharmacol; 2008 Nov; 1(3):244-54. PubMed ID: 20021437
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells.
Bettaieb A; Dubrez-Daloz L; Launay S; Plenchette S; Rébé C; Cathelin S; Solary E
Curr Med Chem Anticancer Agents; 2003 Jul; 3(4):307-18. PubMed ID: 12769775
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 family proteins as targets for anticancer drug design.
Huang Z
Oncogene; 2000 Dec; 19(56):6627-31. PubMed ID: 11426648
[TBL] [Abstract][Full Text] [Related]
13. BCL-2 family antagonists for cancer therapy.
Lessene G; Czabotar PE; Colman PM
Nat Rev Drug Discov; 2008 Dec; 7(12):989-1000. PubMed ID: 19043450
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: new avenues for cancer chemoprevention and chemotherapy.
Pellecchia M; Reed JC
Curr Pharm Des; 2004; 10(12):1387-98. PubMed ID: 15134489
[TBL] [Abstract][Full Text] [Related]
15. Cancer and Apoptosis.
Chaudhry GE; Akim AM; Sung YY; Muhammad TST
Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
[TBL] [Abstract][Full Text] [Related]
16. The Bcl-2 family: structures, interactions and targets for drug discovery.
Kvansakul M; Hinds MG
Apoptosis; 2015 Feb; 20(2):136-50. PubMed ID: 25398535
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic modulation of apoptosis: targeting the BCL-2 family at the interface of the mitochondrial membrane.
Nemec KN; Khaled AR
Yonsei Med J; 2008 Oct; 49(5):689-97. PubMed ID: 18972587
[TBL] [Abstract][Full Text] [Related]
18. Regulators of apoptosis as anticancer targets.
Tolcher AW
Hematol Oncol Clin North Am; 2002 Oct; 16(5):1255-67. PubMed ID: 12512391
[TBL] [Abstract][Full Text] [Related]
19. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
Tomek M; Akiyama T; Dass CR
J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
[TBL] [Abstract][Full Text] [Related]
20. Anticancer drug development based on modulation of the Bcl-2 family core apoptosis mechanism.
Gardner CR
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1157-77. PubMed ID: 15606340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
